![Jennifer Marks: The new NSCLC FDA Oncology approvals](https://oncodaily.com/pub/uploads/2024/08/Thoracic-Oncologist-e1722797830601.png)
Photo from Jennifer Marks/X
Aug 24, 2024, 13:58
Jennifer Marks: The new NSCLC FDA Oncology approvals
Jennifer Marks, Thoracic Oncologist at Georgetown Lombardi, shared a post on X, referencing an earlier post from July 31st 2024:
“An updated version of the previous one given the new NSCLC FDA Oncology approvals: AEGEAN (perioperative durva plus chemo x 4 durva x 1 year) and MARIPOSA (1L ami plus lazer in mEGFR).”
Source: Jennifer Marks/X